These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 18726509)
21. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector. Liu Q; Perez CF; Wang Y J Virol; 2006 Feb; 80(4):1672-9. PubMed ID: 16439524 [TBL] [Abstract][Full Text] [Related]
22. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784 [TBL] [Abstract][Full Text] [Related]
23. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765 [TBL] [Abstract][Full Text] [Related]
24. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Zhang X; De Alwis M; Hart SL; Fitzke FW; Inglis SC; Boursnell ME; Levinsky RJ; Kinnon C; Ali RR; Thrasher AJ Hum Gene Ther; 1999 Oct; 10(15):2527-37. PubMed ID: 10543617 [TBL] [Abstract][Full Text] [Related]
25. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines. Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766 [TBL] [Abstract][Full Text] [Related]
26. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Berthomme H; Fournel S; Epstein AL Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275 [TBL] [Abstract][Full Text] [Related]
27. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus. Logvinoff C; Epstein AL Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553 [TBL] [Abstract][Full Text] [Related]
28. Development of a Novel Recombinant Adeno-Associated Virus Production System Using Human Bocavirus 1 Helper Genes. Wang Z; Cheng F; Engelhardt JF; Yan Z; Qiu J Mol Ther Methods Clin Dev; 2018 Dec; 11():40-51. PubMed ID: 30397626 [TBL] [Abstract][Full Text] [Related]
29. Novel strategy for generation and titration of recombinant adeno-associated virus vectors. Shiau AL; Liu PS; Wu CL J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815 [TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276 [TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector. Ye GJ; Scotti MM; Thomas DL; Wang L; Knop DR; Chulay JD Hum Gene Ther Clin Dev; 2014 Dec; 25(4):212-7. PubMed ID: 25357151 [TBL] [Abstract][Full Text] [Related]
32. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Costantini LC; Jacoby DR; Wang S; Fraefel C; Breakefield XO; Isacson O Hum Gene Ther; 1999 Oct; 10(15):2481-94. PubMed ID: 10543613 [TBL] [Abstract][Full Text] [Related]
33. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas. Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566 [TBL] [Abstract][Full Text] [Related]
34. Development of an insect cell-based adeno-associated virus packaging cell line employing advanced Moreno F; Lip F; Rojas H; Anggakusuma Mol Ther Methods Clin Dev; 2022 Dec; 27():391-403. PubMed ID: 36381303 [TBL] [Abstract][Full Text] [Related]
35. Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences. Trivedi PD; Yu C; Chaudhuri P; Johnson EJ; Caton T; Adamson L; Byrne BJ; Paulk NK; Clément N Mol Ther Methods Clin Dev; 2022 Mar; 24():154-170. PubMed ID: 35071688 [TBL] [Abstract][Full Text] [Related]